Emerging drugs: A medicolegal insight;Drogas emergentes: una perspectiva medicolegal

Revista Espanola de Medicina Legal

Volumn 37, Issue 2, 2011, Pages 76-82

  García Repetto, Rosario ^a   Soria, M Luisa ^a  

^a Biology Section Apdo 863 E 41080   (Spain)

Author keywords

Emerging drugs; Forensic toxicology; Internet; Medicolegal issues

Indexed keywords

EID: 80052475594     PISSN: 03774732     EISSN: 2173917X     Source Type: Journal    
DOI: 10.1016/S0377-4732(11)70067-0     Document Type: Review

References (49)

1. R. Haroz, and M.L. Greenberg Emerging drugs of abuse Med Clin North Am 89 2005 1259 1276 (Pubitemid 41446570)
2. F.T. Peters, and J. Martínez-Ramírez Analytical toxicology of emerging drugs of abuse Ther Drug Monit 32 2010 532 538
3. L. Gussow Coming soon to an ED near you: Bromo-Dragonfly (not an insect), K2 (not a mountain) and Venus (not the planet) Emer Med News 32 2010 20 21
4. European Monitoring Centre for Drugs and Drugs of Abuse, Annual Report 2009: The state of the drug problem in Europe, Office for Official Publications of the European Communities, Luxembourg, 2009 [citado 1 Mar 2011]. Disponible en: http://www.emcdda.europa.eu/publications/annual-report/2009.
5. Schmidt MM, Sharma A, Schifano F, Feinmann C. "Legal highs" on the net. Evaluation of UK based websites, products and product information. Forensic Sci Int. 2011 [en prensa].
6. H.H. Maurer, T. Kraemer, D. Sprienger, and R. Staack Chemistry, pharmacology, toxicology and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazines and pyrrolidinophenone types. A synopsis Ther Drug Monit 26 2004 127 130
7. C. Bye, F.A. Munro, and A.W. Peck A comparison of the effects of 1-bencylpiperazine and dexamphetamine on human performance tests Eur J Clin Pharmacol 6 1973 163 169
8. H. Campbell, W. Cline, and M. Evans Comparison of the effects of dexamphetamine and 1-bencylpiperazine in former addicts Eur J Clin Pharmacol 6 1973 170 176
9. K. Hashimoto, H. Maeda, and T. Goromaru Effects of benzylpiperazine derivatives on neurotoxicity of 3, 4-methylenedioxymetamphetamine in rat brain Brain Res 590 1992 341 344
10. D.L. Murphy, K.P. Lesch, and C.S. Aulakh Serotonin-selective arylpiperazine with neuroendocrine, behavioural, temperature and cardiovascular effects in human Pharmacol Rev 43 1991 527 552
11. M.E. Tancer, and C.E. Johanson The subjective effects of MDMA and mCPP in moderate MDMA users Drug Alcohol Depend 65 2001 97 101 (Pubitemid 33063665)
12. C. Acuña-Castillo, C. Villalobos, and P.R. Moya Differences in potency and efficacy of a series of phenylisopropylamine/phenetylamine pairs and 5-HT (2A) and 5-HT (2C) receptors Br J Pharmacol 136 2002 510 519 (Pubitemid 34717695)
13. V.H. Maddox, E.F. Godefroi, and R.F. Parcell Synthesis of phencyclidine and other 1-arylcyclohexylamines J Med Chem 8 1965 230 235
14. H.H. Maurer Chemistry, pharmacology, and metabolism of emerging drugs of abuse Ther Drug Monitor 32 2010 544 549
15. A.P. Monte, D. Marona-Lewicka, and M.A. Parker Dihydrobenzofuran analogues of hallucinogens 3. Models of 4-substituted (2,5-dimethoxypehynl) alkylamine derivatives with rigified methoxy gropus J Med Chem 39 1996 2953 2961 (Pubitemid 26251033)
16. A.R. Winstock, J. Marsden, and L. Mitcheson What should be done about mephedrone? BMJ 340 2010 1605
17. I. Vardakou, C. Pistos, and Ch. Spiliopoilou Drugs for youth via Internet and the example of mephedrone Toxicol Let 201 2011 191 195
18. A. Parker, D. Marona-Lewicka, V.L. Lucaites, D.L. Nelson, and D.E. Nichols A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptor J Med Chem 41 1998 5148 5149 (Pubitemid 29016308)
19. C. Mustata, M. Torrens, R. Pardo, C. Pérez, and M. Farré Spice drugs: los cannabinoides como nuevas drogas de diseño Adicciones 21 2009 181 186
20. G.I. Stafford, M.E. Pedersen, J. Van Staden, and A. Jäger Review on plants with CNS-effects used in traditional South African medicine against mental diseases J Ethnopharmacology 119 2008 513 517
21. European Monitoring Centre for Drugs and Drugs of Abuse. Actions on new drugs briefing paper: Understanding the Spice Phenomenon. Updated version: 9 Jun 2009.
22. V. Auwärter, S. Dresen, W. Weinmann, M. Müller, M. Pütz, and N. Ferreiros Spice and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spec. 44 2009 832 837
23. K. Babu, E. Boyer, C. Hernon, and E. Brush Emerging drugs of abuse Clin Ped Emerg Med. 6 2005 81 84 (Pubitemid 40932001)
24. F. Yan, B.L. Roth, and A. Salvinorin A novel and highly selective kappa-opioid receptor agonist Life Sci 75 2004 2615 2619 (Pubitemid 39215054)
25. D.J. Siebert Salvia divinorum and salvinorin A: new pharmacologic findings J Ehtnopharmacol 43 1994 53 56 (Pubitemid 24186510)
26. K. Matsumoto, S. Horie, and H. Ishikawa Antinociceptive effect of 7-hydroxymitragynine in mice: discovery of an orally activ opioid analgesic from de Thai medicinal herb Mitragyna speciosa Life Sci 74 2004 2143 2155 (Pubitemid 38210439)
27. H. Takayama Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant Mitagyna speciosa Chem Pharm Bull 52 2004 916 928 (Pubitemid 41701864)
28. European Monitoring Centre for Drugs and Drugs of Abuse Report on the risk assessment of BZP in the framework of the Council Decision on new psychoactive substances. Office for Official Publications of the European Communities Luxembourg 2009
29. The Misuse of Drugs Act 1971 (Amendement) Order 2009, 2009.
30. Orden SAS/1916/2009 de 8 de julio (BOE 17 de julio de 2009). Disponible en: http://www.boe.es/boe/dias/2009/07/17/pdfs/BOE-A-2009-11877.pdf.
31. Orden SPI/201/2011 de 3 de febrero (BOE 9 de febrero de 2011). Disponible en: http://www.boe.es/boe/dias/2011/02/09/pdfs/BOE-A-2011-2490.pdf.
32. G. De Paoli, P.D. Maskell, and D. Pounder Naphyrone: Analytical Profile of the new "legal high" substitute for mephedrone J Forensic Legal Med 18 2011 93
33. R. Garcia-Repetto, E. Moreno, T. Soriano, C. Jurado, M.P. Giménez, and M. Menendez Tissue concentrations of MDMA and its metabolite MDA in three fatal cases of overdose Forensic Sci Int 135 2003 110 114 (Pubitemid 36960216)
34. T.L. Martin Three cases of fatal paramethoxyamphetamine overdose J Anal Toxicol 25 2001 649 651 (Pubitemid 32939076)
35. R.H. Lir, H.C. Liu, and D.L. Lin Distribution of MDMA and MDA in postmortem and antemortem specimens J Anal Toxicol 30 2006 545 550
36. G. Rogers, J. Elston, R. Garside, C. Roone, R. Taylor, and R. Younger The harmful effects of recreational ecstasy: a systematic review of observational evidence Heatlg Technol Asses 13 2009 1 315
37. M. Wikström, P. Holmgren, and J. Ahlner A2 (N-Benzylpiperazine) a New Drug of Abuse in Sweden J Anal Toxicol 28 2004 67 70 (Pubitemid 38112321)
38. D. Wood, P. Dargan, J. Button, D. Holt, H. Ovaska, and J. Ramsey Collapse, reported seizure and an unexpected pill Lancet 369 2007 1490 (Pubitemid 46635785)
39. S. Elliot, and C. Smith Investigation of the first deaths in the United Kingdom involving the detection and quantitation of the piperazines BZP and 3-TFMPP J Anal Toxicol 32 2008 172 177 (Pubitemid 351362752)
40. J. Kovaleva, E. Devyst, P. De Paepe, and A. Vestraete Acute Clorophenylpiperazine overdose: A case report and review of the literature Ther Drug Monitor 30 2008 394 398
41. Europol-EMCDDA Joint Report on a new psychoactive drug: 4-methylcathinone (mephedrone) [citado 30 Oct 2010]. Disponible en: http://www.emcdda.europa.eu/ html.cfm/index116639EN.html.
42. Wood DM, Greene SL, Dargon PI. Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone. Emerg Med J. 2010. Disponible en: http://emj.bmj.com/content/early/2010/06/25/emj.2010.092288.html.
43. H. Torrance, and G. Cooper Detection of mephedrone (4-methylcathinone) in 4 fatalities in Scotland Forensic Sci Int 202 2010 62 63
44. S. Gibbons, and M. Zloh An analysis of the legal high mephedrone Bioorganic & Medicinal Chemistry Letters 20 2010 4135 4139
45. A.J. Dickson, S.P. Vorce, B. Levine, and M. Past Multiple drug toxicity caused by the coadministration of 4-methylcathinone (Mephedrone) and Heroin J Anal Toxicol 34 2010 162 168
46. Lusthof KJ, Oosting R, Maes A, Verschaagen M, Dijkhuizen A, Sprong A. A case of extreme agitation and death after the use of mephedrone in The Netherlands. Forensic Sci Int. 2011 [en prensa].
47. D.M. Wood, J. Looker, Skaikh, J. Bulton, M. Puchnarewicz, and S. Davies Delayed onset of seizures and toxicology associated with recreational use of Bromo Dragon FLY J Med Toxicol 5 2009 226 229
48. M.F. Andreasen, R. Telving, R.I. Bikler, B. Schumarter, and M. Johannsen A fatal poisoning involving Bromo-DragonFly Forensic Sci Int 183 2009 91 96
49. D. Vearrier, and K. Osterhoudt A teenager with agitation Ped Emer Care 26 2010 462 465